Research firm reverses stance on Woodford discount
Kepler had previously claimed Neil Woodford was the victim of ‘tall poppy syndrome’
Investment Trusts
-
-
Merian to shift unquoteds into trust in light of Woodford
£100m fundraise will help Chrysalis buy unquoteds from open-ended range
-
WPCT faces higher borrowing costs as gearing fluctuates
Woodford must now seek permission from Northern Trust before making any investments
-
Woodford Patient Capital could face ETF pressure on FTSE 250 relegation
Index trackers will look to shift holdings ahead of 23 September reshuffle
-
‘Unbiased pair of eyes’ welcomed in WPCT appointment
Appointment of Ruffer co-founder ‘could presage a change in remit’
-
Harry Nimmo prepares to ride out Brexit ‘mayhem’
SLI trust outperforms despite inheriting Patisserie Valerie in merger
-
Woodford welcomes £26m deal after Guernsey setback
Russian investment comes through as Ibiza company causes woes
-
Train welcomes LSE and Refinitiv match-up
$27bn deal would create a credible rival to Bloomberg
-
Baillie Gifford defends crossover between US trust and Oeic
Private companies only make up 10% of NAV
-
Smithson reassures on liquidity as it raises extra £250m
Simon Barnard warns investors not to extrapolate too much from stellar H1 returns
-
Allianz tech trust appoints entrepreneur amid 35% gains
H1 results reveal hit from trade war to semiconductors and hardware
-
Investors slammed Woodford for treating them like charity
Equities manager boasted of government support for patient capital as trust struggled